Analysed PFIZER INC (PFE:NYSE) News Sources
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
10-07-2026
yahoo.com
What is the current price of PFIZER INC (PFE:NYSE)?
The current price of PFIZER INC (PFE:NYSE) is $24.17.
PFIZER INC (PFE:NYSE) absolute price change since previous trading day?
The absolute price change of PFIZER INC (PFE:NYSE) since the previous trading day is $-0.08.
PFIZER INC (PFE:NYSE) percentage price change since previous trading day?
The percentage price change of PFIZER INC (PFE:NYSE) since the previous trading day is -0.3299%.
What is the most recent average sentiment score for PFIZER INC (PFE:NYSE)?
The most recent average sentiment score for PFIZER INC (PFE:NYSE) is 46 out of 100.
What is the most recent average sentiment for PFIZER INC (PFE:NYSE)?
The most recent sentiment for PFIZER INC (PFE:NYSE) is .
SEC-8K** Filing Available For PFIZER INC (PFE:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.